Variants in UGT1A1 and SLCO1B1 increase the risk of neonatal hyperbilirubinemia: a case-control study in subtropical China - Takeaways - MDSpire

Variants in UGT1A1 and SLCO1B1 increase the risk of neonatal hyperbilirubinemia: a case-control study in subtropical China

  • By

  • Wen-Fang Wang

  • Li-Sen Shi

  • Zeng-Wen Xing

  • Yan-Mei Han

  • Wei-Qiang Liu

  • June 24, 2026

  • 0 min

Share

  • 1

    The study evaluated genetic variants in UGT1A1 and SLCO1B1 genes associated with neonatal hyperbilirubinemia in the Haikou population.

  • 2

    A case-control analysis involved 210 neonates with hyperbilirubinemia and 195 healthy controls, assessing genetic polymorphisms and bilirubin levels.

  • 3

    Significant associations were found between specific UGT1A1 and SLCO1B1 genotypes and increased risk of hyperbilirubinemia, with adjusted odds ratios reported.

  • 4

    Cumulative risk analysis indicated that neonates with multiple risk alleles had a markedly elevated risk of hyperbilirubinemia.

  • 5

    The findings suggest that UGT1A1 and SLCO1B1 variants are important genetic biomarkers for predicting neonatal hyperbilirubinemia in subtropical China.

Original Source(s)

Variants in UGT1A1 and SLCO1B1 increase the risk of neonatal hyperbilirubinemia: a case-control study in subtropical China

  • by Wen-Fang Wang, Li-Sen Shi, Zeng-Wen Xing, Yan-Mei Han, Wei-Qiang Liu

  • June 24, 2026

Related Content

Beyond Functional Independence: Symptom Burden and Emotional Difficulties in Pediatric Long COVID — A Cross-Sectional Exploratory Study

Beta-2 Agonists Tied to ASD Risk?

Systematic review of 8 observational studies found limited evidence on associations between prenatal asthma-medication exposure and neurodevelopmental outcomes, with autism spectrum disorder the only outcome suitable for meta-analysis.

Efficacy and safety of phototherapy for jaundice in full-term newborns: a meta-analysis